Ageagle Aerial Systems Inc

UAVS

$1.21

Closing

▼-5.47%

1D

▼-42.33%

YTD

Market cap

$9.12M

52 week high

$10.20

52 week low

$1.12

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$9.12M

Analysts' Rating

-

Price Target (Mean)

-

Total Analysts

0

P/E

Operating Margin

-215.68%

Beta

3.72

Revenue Growth (Annual)

95.62%

52 week high

$10.20

52 week low

$1.12

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

AgEagle Aerial Systems Inc. is engaged in designing and delivering drones, sensors, and software that solve problems for its customers. The Company is a provider of full stack drone solutions for customers in the energy, construction, agriculture, and government verticals. The Company operates through three segments: Drones, Sensors, and Software-as-a-Service (SaaS). Its Drones segment comprises contractual arrangements to develop, manufacture, and/or modify complex drone-related products, and to provide associated engineering, technical, and other services according to customer specifications. The Sensors segment comprises the sale of sensors, cameras, and related accessories. The SaaS segment offers online-based subscriptions. The Company has business operations in Austin, Texas; Lausanne, Switzerland; Raleigh, North Carolina; Seattle, Washington, and Washington, District of Columbia (D.C.).